Tarceva Gets Green Light for Cancer Treatment
3rd Nov 2005, 18:03 GMT
The Food and Drug Administration approved a lung cancer medication Wednesday as a new treatment for pancreatic cancer. Tarceva can help patients live a little longer.
Tarceva Gets Green Light for Cancer Treatment related news:
- Tarceva OK'd for cancer of pancreas — USATODAY.com Health - Top Stories
- Tarceva Approved for Treatment of Pancreatic Cancer — MedPage Today OB/GYN
- Tarceva gets FDA go-ahead for pancreatic cancer treatment — The Earth Times Online Newspaper
- FDA Approves Tarceva in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer — Partnerships/ Joint Ventures News from StratCenter.com
- Lung cancer drug approved for treating pancreatic cancer — News-Medical News Feed
- Tarceva Drug OK'd for Pancreatic Cancer — Pharmaceuticals News from StratCenter.com
- Multimedia News Release -- FDA Approves Tarceva(R) in Combination With Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer — PR Newswire: All Releases
- Tarceva: The 'Enemy' of Pancreatic Cancer, Approved by the FDA — Softpedia - Latest news
- Tarceva Approved for Pancreatic Cancer — TheStreet.com
- Fatherhood possible for many testicular cancer survivors, study finds — EurekAlert! - Cancer
Latest news from Sci-Tech Today:
- Hunger a Big Enemy in War on AIDS
- Critics Say U.N. Climate Talks Lagging
- NASA's Surveyor Loses Contact for a Week
- Study: Waltzing Helps Mend Hearts
- Hospitals Want Faster Heart Attack Care
- Muslim Clerics Fighting Polio in India
- Results Mixed on Merck's New Painkiller
- Report To Offer New Climate Change Evidence
- Which Is Safer: Internet Explorer 7 or Firefox 2.0?
- Shuttle Crew Prepares for December Launch